Previous studies have shown that the anionic alkali mineral complex BARODON has an immunoenhancing effect on pigs as an adjuvant and as a nonspecific immunostimulant. Likewise, the equine immune system has been defined with various monoclonal antibodies specific to equine leukocyte differentiation antigens to determine the possibility of enhancing equine resistance to respiratory diseases and promoting other immunostimulatory effects with the application of BARODON. Compared with the control group, after 3 weeks of treatment, BARODON-treated groups showed higher proportions of cells (P < 0.05) expressing major histocompatibility complex class II and CD2, CD4؉ , CD4 ؉ CD25 ؉ , CD8 ؉ , and CD8 ؉ CD25 ؉ T lymphocytes, dendritic cells, and surface immunoglobulin M ؉ B lymphocytes in peripheral blood, as well as enhanced cell proliferative responses with phytohemagglutinin and increased phagocytic activity against Streptococcus equi and Staphylococcus aureus strains with high antibiotic resistance, the bacteria frequently identified as etiologic agents of equine respiratory diseases at the Seoul Race Park in Seoul, Korea. This study shows that BAR-ODON may act as an immunostimulator and can be an effective alternative to antimicrobial feed additives for nonspecific improvements in equine immune responses, particularly against respiratory diseases.Equine respiratory disease is believed to be the second most important cause of poor performance, interruption of training, and premature retirement among performance horses (41,50,61,62,72). In Seoul, Korea, the Seoul Race Park experienced yearly epizootics of infectious upper respiratory diseases (IURD), with an estimated incidence of 29.6%, from 2001 to 2005. IURD affects the nasal passages and throat region and results in chronic coughing, exercise intolerance, weight loss, and nasal discharge